Skip to content
TrialScanner

NCT04987658

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

Phase 1CompletedALKSLead

Registry record

Lead sponsor
Alkermes, Inc.
Conditions
Bipolar I Disorder
Primary completion
Aug 11, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04987658 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04987658: Phase 1 Study of OLZ/SAM in... | TrialScanner